Avion Wealth’s PMV Pharmaceuticals PMVP Stock Holding History

Avion Wealth’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-299	Closed	-$1K	–	1182
2024 Q1	$1K	Buy	+299	New	+$558	﹤0.01%	1036

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Avion Wealth's PMVP Position: Q2 2024 in Review

Avion Wealth sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 299 shares — an estimated $1K sold.

Avion Wealth first reported a position in PMVP in Q1 2024 and held it in 1 quarter. The position peaked at $1K in Q1 2024. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

Avion Wealth reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Avion Wealth sold 299 PMV Pharmaceuticals shares in Q2 2024, an estimated $1K.
Avion Wealth first reported a position in PMV Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Avion Wealth's PMV Pharmaceuticals position peaked at $1K in Q1 2024.
93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Avion Wealth's 13F filing for Q2 2024, filed 26 Jul 2024.